文献速递慢性肾脏病

慢性肾脏病的早期识别——全球人群的范围综述

Early Identification of CKD-A Scoping Review of the Global Populations.
PubMed 文献 · Kidney Int Rep · 2022-04-06

目标人群筛查的慢性肾脏病3-5期报告患病率高于人群筛查(14.8% vs 8.0%),需筛查人数也更低(7 vs 13)。仅2.8%的研究包含药物干预,30.1%的国家有早期识别政策。

要点

  • 全球慢性肾脏病早期识别方法差异大,报告患病率波动明显。
  • 目标人群筛查的慢性肾脏病3-5期患病率14.8%,高于人群筛查的8.0%。
  • 仅2.8%的研究对检出的慢性肾脏病病例提供药物等干预。

核心结论

  • 全球慢性肾脏病早期识别方法各异,常导致报告患病率差异较大;标准化测量方法、聚焦高危人群并确保检出者获得适当干预,可提升项目价值并改善患者结局。

主要发现

  • 97.6%的项目以检测慢性肾脏病为目标,63.1%采用人群筛查方法,仅12.4%涉及农村人群。
  • 目标人群研究的慢性肾脏病3-5期报告患病率为14.8%,高于人群筛查研究的8.0%;需筛查人数分别为7和13。
  • 80%的研究使用单次测量,71.4%联合估算肾小球滤过率与尿液检测(白蛋白尿/蛋白尿)来检测慢性肾脏病。
  • 仅2.8%的研究对检出的病例包含药物干预等干预措施;30.1%的纳入国家有早期识别政策。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Decisions on whether to screen for chronic kidney disease (CKD) or not remain contentious in nephrology. This study provides a global overview of early CKD identification efforts. METHODS: Guidelines for scoping reviews were followed and studies were identified by searching MEDLINE, EMBASE, Cochrane Library, CINAHL, ISI Web of Science, and PsycINFO. Data extracted from included studies focused on the following 4 themes: study population, measurement methods, interventions used, and available policies. RESULTS: We identified 290 CKD screening and detection programs from 83 countries. Overall sample size was 3.72 million (North East Asia: 1.19 million), detection of CKD was the aim in 97.6%, 63.1% used population-based screening methods, and only 12.4% were in rural populations. Reported CKD prevalence (stages 3-5) was higher in targeted- (14.8%) than population-based studies (8.0%). Number of persons needed to screen (NNS) to identify 1 case was also lower in targeted studies (7 vs. 13). Single measurements (80%) and the combination of estimation of glomerular filtration rate with a urine test (albuminuria/proteinuria) (71.4%) were frequently used to detect CKD. Only 2.8% of studies included an intervention such as pharmacotherapy in identified cases. Policies on early identification were available in 30.1% of countries included. CONCLUSION: Methods for early CKD identification vary worldwide, often leading to wide variations in the reported prevalence. Efforts to standardize measurement methods for early detection focusing on high-risk populations and ensuring appropriate interventions are available to those identified with CKD will improve the value of programs and improve patient outcomes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Okpechi IG, Caskey FJ, Gaipov A, et al. Early Identification of CKD-A Scoping Review of the Global Populations. Kidney Int Rep. 2022. PMID: 35685314. doi:10.1016/j.ekir.2022.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。